• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

粪便微生物群移植的当前趋势与挑战——一种适用于所有人的简便方法?

Current Trends and Challenges of Fecal Microbiota Transplantation-An Easy Method That Works for All?

作者信息

Almeida Cátia, Oliveira Rita, Baylina Pilar, Fernandes Rúben, Teixeira Fábio G, Barata Pedro

机构信息

LaBMI-Laboratory of Medical & Industrial Biotechnology, Porto Polytechnic Institute, 4200-375 Porto, Portugal.

Department of Biomedicine, Unit of Biochemistry, Faculty of Medicine of Porto University, 4200-319 Porto, Portugal.

出版信息

Biomedicines. 2022 Oct 28;10(11):2742. doi: 10.3390/biomedicines10112742.

DOI:10.3390/biomedicines10112742
PMID:36359265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9687574/
Abstract

The gut microbiota refers to bacteria lodges in the gastrointestinal tract (GIT) that interact through various complex mechanisms. The disturbance of this ecosystem has been correlated with several diseases, such as neurologic, respiratory, cardiovascular, and metabolic diseases and cancer. Therefore, the modulation of the gut microbiota has emerged as a potential therapeutic tool; of the various forms of gut microbiota modulation, fecal microbiota transplantation (FMT) is the most approached. This recent technique involves introducing fecal material from a healthy donor into the patient's gastrointestinal tract, aiming to restore the gut microbiota and lead to the resolution of symptoms. This procedure implies a careful donor choice, fine collection and handling of fecal material, and a balanced preparation of the recipient and consequent administration of the prepared content. Although FMT is considered a biological therapy with promising effects, side effects such as diarrhea and abdominal pain have also been claimed, making this a significant challenge in the application of FMT. Bearing this in mind, the present review aims to summarize the recent advances in understanding FMT mechanisms, their impact across different pathological conditions, and the associated side effects, emphasizing the most recent published data.

摘要

肠道微生物群是指寄居于胃肠道(GIT)的细菌,它们通过各种复杂机制相互作用。这种生态系统的紊乱与多种疾病相关,如神经、呼吸、心血管和代谢疾病以及癌症。因此,调节肠道微生物群已成为一种潜在的治疗手段;在各种调节肠道微生物群的形式中,粪便微生物群移植(FMT)是应用最为广泛的。这项新技术包括将来自健康供体的粪便物质引入患者胃肠道,旨在恢复肠道微生物群并缓解症状。该程序需要仔细选择供体,精细收集和处理粪便物质,以及对受体进行适当准备并随后给予制备好的内容物。尽管FMT被认为是一种具有显著疗效的生物疗法,但腹泻和腹痛等副作用也时有报道,这使得FMT的应用面临重大挑战。鉴于此,本综述旨在总结在理解FMT机制、其在不同病理状况下的影响以及相关副作用方面的最新进展,重点强调最新发表的数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/145a/9687574/ef4a335e6776/biomedicines-10-02742-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/145a/9687574/afd81e5dbb61/biomedicines-10-02742-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/145a/9687574/ef4a335e6776/biomedicines-10-02742-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/145a/9687574/afd81e5dbb61/biomedicines-10-02742-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/145a/9687574/ef4a335e6776/biomedicines-10-02742-g002.jpg

相似文献

1
Current Trends and Challenges of Fecal Microbiota Transplantation-An Easy Method That Works for All?粪便微生物群移植的当前趋势与挑战——一种适用于所有人的简便方法?
Biomedicines. 2022 Oct 28;10(11):2742. doi: 10.3390/biomedicines10112742.
2
The Role of Fecal Microbiota Transplantation (FMT) in the Management of Metabolic Diseases in Humans: A Narrative Review.粪便微生物群移植(FMT)在人类代谢性疾病管理中的作用:一项叙述性综述。
Biomedicines. 2024 Aug 16;12(8):1871. doi: 10.3390/biomedicines12081871.
3
Gut microbiota alteration and modulation in psychiatric disorders: Current evidence on fecal microbiota transplantation.精神疾病中肠道微生物群的改变与调节:粪便微生物群移植的当前证据
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jul 13;109:110258. doi: 10.1016/j.pnpbp.2021.110258. Epub 2021 Jan 23.
4
Fecal microbiota transplantation in disease therapy.粪便微生物群移植在疾病治疗中的应用。
Clin Chim Acta. 2020 Apr;503:90-98. doi: 10.1016/j.cca.2019.12.010. Epub 2020 Jan 20.
5
Fecal microbiota transplantation for gastrointestinal diseases.用于胃肠道疾病的粪便微生物群移植
Keio J Med. 2014;63(4):69-74. doi: 10.2302/kjm.2014-0006-RE. Epub 2014 Dec 15.
6
[Fecal microbiota transplantation].[粪便微生物群移植]
Vnitr Lek. 2016 Feb;62(2):147-51.
7
Pick fecal microbiota transplantation to enhance therapy for major depressive disorder.选择粪便微生物群移植以加强对重度抑郁症的治疗。
Prog Neuropsychopharmacol Biol Psychiatry. 2024 Jan 10;128:110860. doi: 10.1016/j.pnpbp.2023.110860. Epub 2023 Sep 9.
8
From Donor to Patient: Collection, Preparation and Cryopreservation of Fecal Samples for Fecal Microbiota Transplantation.从供体到患者:用于粪便微生物群移植的粪便样本的采集、制备和冷冻保存
Diseases. 2020 Apr 15;8(2):9. doi: 10.3390/diseases8020009.
9
Standardized Preparation for Fecal Microbiota Transplantation in Pigs.猪粪便微生物群移植的标准化制备
Front Microbiol. 2018 Jun 19;9:1328. doi: 10.3389/fmicb.2018.01328. eCollection 2018.
10
Separation of Donor and Recipient Microbial Diversity Allows Determination of Taxonomic and Functional Features of Gut Microbiota Restructuring following Fecal Transplantation.供体和受体微生物多样性的分离有助于确定粪便移植后肠道微生物群重组的分类学和功能特征。
mSystems. 2021 Aug 31;6(4):e0081121. doi: 10.1128/mSystems.00811-21. Epub 2021 Aug 17.

引用本文的文献

1
The Role of Gut Microbiota in the Development and Treatment of Obesity and Overweight: A Literature Review.肠道微生物群在肥胖和超重的发生发展及治疗中的作用:文献综述
J Clin Med. 2025 Jul 11;14(14):4933. doi: 10.3390/jcm14144933.
2
Impact of Gut Microbiome on Gut Permeability in Liver and Gut Diseases.肠道微生物群对肝脏和肠道疾病中肠道通透性的影响。
Microorganisms. 2025 May 23;13(6):1188. doi: 10.3390/microorganisms13061188.
3
Fecal Microbiota Transplantation Using Donor Stool Obtained from Exercised Mice Suppresses Colonic Tumor Development Induced by Azoxymethane in High-Fat Diet-Induced Obese Mice.

本文引用的文献

1
Different gender-derived gut microbiota influence stroke outcomes by mitigating inflammation.不同性别来源的肠道微生物群通过减轻炎症影响中风的结果。
J Neuroinflammation. 2022 Oct 4;19(1):245. doi: 10.1186/s12974-022-02606-8.
2
Fecal microbiota transplantation versus glucocorticoids for the induction of remission in mild to moderate ulcerative colitis.粪便微生物群移植与糖皮质激素治疗轻中度溃疡性结肠炎诱导缓解的比较。
J Transl Med. 2022 Aug 12;20(1):354. doi: 10.1186/s12967-022-03569-3.
3
Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients.
使用从运动小鼠获得的供体粪便进行粪便微生物群移植可抑制高脂饮食诱导的肥胖小鼠中由氧化偶氮甲烷诱导的结肠肿瘤发展。
Microorganisms. 2025 Apr 27;13(5):1009. doi: 10.3390/microorganisms13051009.
4
Impact of bacteroides uniformis on fatty liver hemorrhagic syndrome in dawu golden phoenix laying hens: modulation of gut microbiota and arachidonic acid metabolism.解脲拟杆菌对大悟金凤凰蛋鸡脂肪肝出血综合征的影响:肠道微生物群和花生四烯酸代谢的调节
Front Microbiol. 2025 Apr 28;16:1560887. doi: 10.3389/fmicb.2025.1560887. eCollection 2025.
5
The Respiratory Tract Microbiome and Human Health.呼吸道微生物群与人类健康
Microb Biotechnol. 2025 May;18(5):e70147. doi: 10.1111/1751-7915.70147.
6
Targeting the Endocannabinoidome: A Novel Approach to Managing Extraintestinal Complications in Inflammatory Bowel Disease.靶向内源性大麻素系统:一种治疗炎症性肠病肠外并发症的新方法。
Pharmaceuticals (Basel). 2025 Mar 27;18(4):478. doi: 10.3390/ph18040478.
7
"Gut Microbiota as a Therapeutic Target for Hypertension: Challenges and Insights for Future Clinical Applications" "Gut Microbiota and Hypertension Therapy".“作为高血压治疗靶点的肠道微生物群:未来临床应用的挑战与见解” “肠道微生物群与高血压治疗”
Curr Hypertens Rep. 2025 Apr 22;27(1):14. doi: 10.1007/s11906-025-01331-w.
8
Faecal microbiota transplantation for recurrent Clostridiodes difficile infection & its global regulatory landscape.粪菌移植治疗复发性艰难梭菌感染及其全球监管格局。
Indian J Med Res. 2025 Feb;161(2):113-119. doi: 10.25259/IJMR_818_2024.
9
Microbiome Integrity Enhances the Efficacy and Safety of Anticancer Drug.微生物群完整性增强抗癌药物的疗效和安全性。
Biomedicines. 2025 Feb 10;13(2):422. doi: 10.3390/biomedicines13020422.
10
Global bibliometric analysis of traditional Chinese medicine regulating gut microbiota in the treatment of diabetes from 2004 to 2024.2004年至2024年中医调节肠道微生物群治疗糖尿病的全球文献计量分析
Front Pharmacol. 2025 Jan 23;16:1533984. doi: 10.3389/fphar.2025.1533984. eCollection 2025.
前瞻性研究揭示了 2 型糖尿病患者接受粪便微生物群移植治疗的临床应答的宿主微生物决定因素。
Front Cell Infect Microbiol. 2022 Mar 25;12:820367. doi: 10.3389/fcimb.2022.820367. eCollection 2022.
4
Changes in colonic enteroendocrine cells of patients with irritable bowel syndrome following fecal microbiota transplantation.肠易激综合征患者粪便微生物群移植后结肠肠内分泌细胞的变化。
Scand J Gastroenterol. 2022 Jul;57(7):792-796. doi: 10.1080/00365521.2022.2036809. Epub 2022 Feb 14.
5
Health improvements of type 2 diabetic patients through diet and diet plus fecal microbiota transplantation.通过饮食和饮食加粪便微生物群移植改善 2 型糖尿病患者的健康状况。
Sci Rep. 2022 Jan 21;12(1):1152. doi: 10.1038/s41598-022-05127-9.
6
Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial.冻干口服粪便微生物群移植治疗溃疡性结肠炎(LOTUS):一项随机、双盲、安慰剂对照试验。
Lancet Gastroenterol Hepatol. 2022 Feb;7(2):141-151. doi: 10.1016/S2468-1253(21)00400-3. Epub 2021 Dec 2.
7
Efficacy and Safety of Washed Microbiota Transplantation to Treat Patients with Mild-to-Severe COVID-19 and Suspected of Having Gut Microbiota Dysbiosis: Study Protocol for a Randomized Controlled Trial.经洗涤的微生物群移植治疗轻至重度 COVID-19 患者和疑似肠道微生物群失调的疗效和安全性:一项随机对照试验的研究方案。
Curr Med Sci. 2021 Dec;41(6):1087-1095. doi: 10.1007/s11596-021-2475-2. Epub 2021 Nov 30.
8
Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center.炎症性肠病患者复发性艰难梭菌感染的粪便微生物群移植:大容量欧洲 FMT 中心的经验。
Gut Microbes. 2021 Jan-Dec;13(1):1994834. doi: 10.1080/19490976.2021.1994834.
9
The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide survey.欧洲粪便微生物群移植(FMT)的应用:一项全欧洲范围的调查。
Lancet Reg Health Eur. 2021 Jul 19;9:100181. doi: 10.1016/j.lanepe.2021.100181. eCollection 2021 Oct.
10
Fecal microbiota transplantation and fiber supplementation, better together?粪便微生物移植与膳食纤维补充,相得益彰?
Cell Rep Med. 2021 Sep 23;2(9):100403. doi: 10.1016/j.xcrm.2021.100403. eCollection 2021 Sep 21.